Delivery Order SPE2DE21D7020-SPE2D626F44B6
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,094.40 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 17, 2025. This fixed-price contract with economic price adjustment was awarded on December 10, 2025, and is issued without a small business set-aside. The delivery order is placed against Boston Scientific's single-award Blanket Purchase Agreement with the Defense...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on December 5, 2025, with an ultimate completion date of December 12, 2025, is designated as a fixed-price delivery order with economic price adjustment provisions. This award is issued without small business set-aside restrictions, allowing Boston Scientific to compete on an unrestricted...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $19,920.74 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of November 18, 2025. This delivery order, issued on November 10, 2025, is a non-set-aside award issued without small business restrictions. The contract utilizes fixed-price pricing with economic price adjustment terms and represents a task order issued against Boston...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $23,660 under the Defense Health Agency's Medical Supply Chain Blanket Purchase Agreement on August 25, 2025, with an ultimate completion date of September 2, 2025. The contract employs fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's single-award BPA with the Defense...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division, effective October 24, 2025, with an ultimate completion date of October 31, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing single-award...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a $4,048 delivery order by the Defense Health Agency's Medical Supply Chain on October 28, 2025, with an ultimate completion date of November 4, 2025. This delivery order operates under a fixed-price contract with economic price adjustment terms and is issued against a larger single-award Blanket Purchase Agreement valued at $750,000, which designates Boston Scientific as the sole...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,648.74 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 29, 2025. This fixed-price contract with economic price adjustment provisions was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The delivery order is issued against Boston Scientific's existing Blanket...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $3,354.55 by the Defense Health Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by November 12, 2025. The award was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The delivery order is issued against Boston Scientific's...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a $7,678 fixed-price delivery order (Contract No. 4570351147) by the Defense Health Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 18, 2025. This delivery order, issued without a small business set-aside, procures medical equipment or devices under the company's existing Blanket Purchase Agreement with the Defense Health Agency valued at $750,000 with a completion...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,327.08 by the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority was awarded on October 15, 2025, with an ultimate completion date of October 22, 2025. The delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency, a single-award indefinite delivery...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F44B6Delivery Order
Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a $50,958.24 fixed-price delivery order by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of December 29, 2025. This delivery order, issued on December 19, 2025, is executed against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency valued at $750,000 (completion date March 30, 2030). The BPA, awarded on March 31, 2025, designates Boston Scientific as the sole supplier for radiation treatment devices and represents an indefinite delivery vehicle that enables the agency to streamline procurement of specialized radiation oncology equipment. The contract carries fixed-price terms with economic price adjustment provisions and includes no small business set-aside designation. As a leading global medical technology company specializing in advanced medical devices across multiple therapeutic areas, Boston Scientific fulfills critical resupply requirements for yttrium-90 radiopharmaceuticals and related radiation treatment technologies across military healthcare facilities and Veterans Affairs medical centers. This delivery order demonstrates the federal government's continued confidence in Boston Scientific's capability to reliably deliver complex, specialized medical devices while maintaining supply chain continuity for cancer treatment modalities essential to the defense and veterans healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.0k | 12/18/25 |